{"version":"1.0","type":"link","title":"Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).","author_name":"Slomovitz BM 외","author_url":"https://prs-insight.online/author/Slomovitz%20BM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89170","thumbnail_width":1200,"thumbnail_height":630}